2Indexed trials
drug · Product Intelligence
Bupivacaine
Pipeline Intelligence
Bupivacaine: 2 indexed trials, 2 sponsors; 16 linked Orange Book patents and 12 FDA-linked events where matched.
2Sponsors
16Orange Book patent links
12FDA-linked events
Development evidence
NCT02971540Medical University of Silesia · out_of_scopeNA
NCT03067740Zagazig University · pain_neuropathyPHASE4
FDA / patent evidence
11844837ZYNRELEF KIT · app 2119882036-04-21
9694079ZYNRELEF KIT · app 2119882035-04-20
10898575ZYNRELEF KIT · app 2119882035-04-20
9801945ZYNRELEF KIT · app 2119882035-04-20
10098957ZYNRELEF KIT · app 2119882035-04-20
10632199ZYNRELEF KIT · app 2119882035-04-20
11083730ZYNRELEF KIT · app 2119882035-04-20
11083797ZYNRELEF KIT · app 2119882035-04-20
10213510ZYNRELEF KIT · app 2119882035-04-20
11413350ZYNRELEF KIT · app 2119882035-04-20
10980886ZYNRELEF KIT · app 2119882035-04-20
9913909ZYNRELEF KIT · app 2119882034-03-13
Regulatory context
FDA_EXCLUSIVITYZYNRELEF KIT · I-9332027-01-23
FDA_APPROVALBUPIVACAINE HYDROCHLORIDE · 2026-04-22
FDA_APPROVALBUPIVACAINE HYDROCHLORIDE · 2024-03-27
FDA_APPROVALBUPIVACAINE HYDROCHLORIDE · 2023-11-20
FDA_APPROVALZYNRELEF KIT · 2021-05-12
FDA_APPROVALBUPIVACAINE HYDROCHLORIDE PRESERVATIVE FREE · 2021-02-11
FDA_APPROVALBUPIVACAINE HYDROCHLORIDE · 2019-04-02
FDA_APPROVALBUPIVACAINE HYDROCHLORIDE · 2019-02-19
FDA_APPROVALBUPIVACAINE HYDROCHLORIDE · 2016-07-25
FDA_APPROVALBUPIVACAINE HYDROCHLORIDE · 2016-05-13
FDA_APPROVALBUPIVACAINE HYDROCHLORIDE · 1987-12-11
FDA_APPROVALBUPIVACAINE HYDROCHLORIDE AND EPINEPHRINE · 1983-07-13
FDA Orange Book coverage is U.S.-specific and is not a substitute for worldwide patent or regulatory review.